SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-15-012793
Filing Date
2015-06-24
Accepted
2015-06-24 07:44:06
Documents
5
Period of Report
2015-06-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdli20150623_8k.htm 8-K 32065
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 33558
3 EXHIBIT 99.1 ex99-1.htm EX-99.1 9963
4 ex99-1img001.jpg GRAPHIC 4063
5 logo.jpg GRAPHIC 8745
  Complete submission text file 0001437749-15-012793.txt   94820
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 15948247
SIC: 2836 Biological Products, (No Diagnostic Substances)